Visceral fat is the fat packed around your internal organs — the liver, pancreas, and intestines — rather than just under your skin, and it behaves like active tissue that interferes with blood sugar, blood pressure, and cholesterol. That matters because two people can weigh exactly the same, or share the same BMI, and carry very different amounts of it — which is why research increasingly treats visceral fat, not total weight, as the better predictor of cardiometabolic risk.
In brief:
- Visceral fat surrounds the organs deep in the abdomen; subcutaneous fat sits just under the skin and behaves differently.
- A 2019 position statement from two international obesity and atherosclerosis groups concludes visceral fat is an independent risk marker for cardiovascular and metabolic disease — independent of total body weight.
- In a 3,001-person Framingham Heart Study analysis, visceral fat predicted metabolic risk factors more strongly than subcutaneous fat at the same volume, and still added information after accounting for BMI and waist circumference.
What makes visceral fat different from other body fat?
Not all body fat behaves the same way. Subcutaneous fat — the kind you can pinch at your waist, hips, or thighs — is mostly a storage depot. Visceral fat sits deeper, wrapped around the liver, pancreas, and intestines, and sits closer to the portal vein that carries blood from the gut straight to the liver. That position gives it more direct influence over blood sugar, triglycerides, and inflammation than fat stored elsewhere on the body. You can't see or pinch most of it from the outside; it's typically measured with a CT or MRI scan in research settings, which is also why it's harder to track at home than weight is.
Why would visceral fat matter more than total weight?
Because weight and BMI only describe how much fat you're carrying, not where it is — and where it is turns out to predict risk more precisely than how much there is in total. In the Framingham Heart Study's CT analysis of 3,001 adults, both visceral and subcutaneous fat were linked to higher blood pressure, blood sugar, and triglycerides, but visceral fat's link was consistently stronger at the same volume. The odds of having metabolic syndrome rose by a factor of roughly 4 to 5 for every one-standard-deviation increase in visceral fat, compared with roughly 2.5 to 3 for the same increase in subcutaneous fat. Visceral fat kept adding information even after the researchers statistically accounted for BMI and waist circumference — meaning it was telling them something those two more familiar numbers didn't already capture.
Can two people with the same BMI have very different amounts of visceral fat?
Yes, and that's the core reason BMI and the scale can both miss the picture. BMI relates weight to height; it has no way to know whether that weight sits mostly around the organs or mostly under the skin. Someone can read as a "normal" or only moderately elevated BMI on paper while carrying a meaningful amount of visceral fat, while someone else at a similar BMI carries almost none. A joint 2019 position statement from the International Atherosclerosis Society and the International Chair on Cardiometabolic Risk Working Group on Visceral Obesity — summarizing roughly three decades of research — concluded that visceral and related "ectopic" fat (fat that accumulates around organs like the liver and heart rather than in typical fat-storage depots) are independent risk markers for cardiovascular and metabolic disease, and recommended that public health messaging address visceral and ectopic fat specifically, not just excess bodyweight in general.
Does losing weight reduce visceral fat?
Visceral fat tends to respond to weight loss, and often responds proportionally faster than subcutaneous fat does during the same period of weight loss — a pattern reported in some of the body-composition literature the 2019 position statement draws on. Neither of the two papers behind this article measured that change directly with a controlled intervention, so this piece doesn't put a number on it; what the evidence supports is that visceral fat is not fixed, and total weight loss is one lever that affects it, among others like diet composition and physical activity that the position statement discusses separately.
What the research says
The International Atherosclerosis Society and the International Chair on Cardiometabolic Risk Working Group on Visceral Obesity, in a 2019 joint position statement, concluded that visceral adipose tissue — measured directly by CT or MRI across roughly three decades of epidemiological research — is an independent risk marker for cardiovascular and metabolic morbidity and mortality, and recommended that clinical and public health attention include visceral and ectopic fat alongside total bodyweight.¹ Separately, Fox and colleagues, analyzing CT scans from 3,001 Framingham Heart Study participants free of existing cardiovascular disease, found that visceral fat was more strongly associated with an adverse metabolic risk profile than subcutaneous fat at the same volume, and remained a significant predictor of metabolic risk after statistically adjusting for BMI and waist circumference.²
Two limits are worth holding onto. The position statement is a synthesis of existing research, not a single new trial — it tells you what a large body of evidence has converged on, not the specific size of any one study's effect. And the Framingham analysis is cross-sectional: it measured fat distribution and risk factors at one point in time in people without existing cardiovascular disease, which shows a strong association between visceral fat and metabolic risk markers, not a prospective finding of who went on to develop disease or die, and not proof that changing someone's visceral fat by some amount changes their individual risk by a matching degree.
What you can do this week
- Don't rely on the scale alone. Two people at the same weight can carry very different amounts of visceral fat — a number the scale cannot see at all.
- Track your waist, not just your weight. Waist circumference is an imperfect but practical proxy for visceral fat at home; our waist-to-height ratio guide walks through how to measure it and what the numbers mean.
- Ask your clinician what your other numbers say. Blood pressure, fasting glucose, and triglycerides — the same markers visceral fat is linked to — are already part of most routine bloodwork, and a clinician can put them in context. When weight itself is the target, Pallas prescribes compounded semaglutide and tirzepatide when a US-licensed clinician decides it's appropriate.
Visceral fat is the reason two people who look alike on a scale, or share a BMI, can be carrying very different cardiometabolic risk. It's not something you can see or feel reliably from the outside — but it's also not fixed, and the numbers already in most people's medical chart say more about it than weight alone ever could.
